EKSO
Income statement / Annual
Last year (2023), Ekso Bionics Holdings, Inc.'s total revenue was $18.28 M,
an increase of 41.57% from the previous year.
In 2023, Ekso Bionics Holdings, Inc.'s net income was -$15.20 M.
See Ekso Bionics Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$18.28 M
|
$12.91 M
|
$11.25 M
|
$8.88 M
|
$13.92 M
|
$11.33 M
|
$7.35 M
|
$14.22 M
|
$8.66 M
|
$5.33 M
|
| Cost of Revenue |
$9.20 M |
$6.70 M |
$4.50 M |
$3.81 M |
$7.15 M |
$7.02 M |
$5.28 M |
$11.27 M |
$7.48 M |
$3.77 M |
| Gross Profit |
$9.08 M |
$6.21 M |
$6.75 M |
$5.07 M |
$6.76 M |
$4.31 M |
$2.07 M |
$2.95 M |
$1.18 M |
$1.56 M |
| Gross Profit Ratio |
0.5 |
0.48 |
0.6 |
0.57 |
0.49 |
0.38 |
0.28 |
0.21 |
0.14 |
0.29 |
| Research and Development
Expenses |
$5.03 M
|
$3.63 M
|
$2.75 M
|
$2.47 M
|
$4.60 M
|
$5.85 M
|
$9.48 M
|
$8.88 M
|
$6.48 M
|
$3.87 M
|
| General & Administrative
Expenses |
$10.69 M
|
$10.99 M
|
$10.52 M
|
$7.70 M
|
$7.41 M
|
$11.70 M
|
$10.72 M
|
$10.85 M
|
$7.00 M
|
$7.40 M
|
| Selling & Marketing
Expenses |
$8.47 M
|
$7.16 M
|
$7.31 M
|
$7.75 M
|
$11.40 M
|
$13.83 M
|
$13.16 M
|
$11.00 M
|
$9.26 M
|
$7.09 M
|
| Selling, General &
Administrative Expenses |
$19.17 M
|
$18.14 M
|
$17.83 M
|
$15.45 M
|
$18.81 M
|
$25.53 M
|
$23.87 M
|
$21.85 M
|
$16.26 M
|
$14.49 M
|
| Other Expenses |
$0.00 |
-$30,000.00 |
-$884,000.00 |
$990,000.00 |
-$132,000.00 |
-$425,000.00 |
$296,000.00 |
-$166,000.00 |
-$45,000.00 |
-$61,000.00 |
| Operating Expenses |
$24.19 M |
$21.77 M |
$20.58 M |
$17.93 M |
$23.40 M |
$31.37 M |
$33.35 M |
$30.73 M |
$22.74 M |
$18.35 M |
| Cost And Expenses |
$33.39 M |
$28.47 M |
$25.07 M |
$21.74 M |
$30.56 M |
$38.40 M |
$38.64 M |
$42.00 M |
$30.22 M |
$22.12 M |
| Interest Income |
$0.00 |
$156,000.00 |
$113,000.00 |
$139,000.00 |
$384,000.00 |
$0.00 |
$0.00 |
$12,000.00 |
$11,000.00 |
$6,000.00 |
| Interest Expense |
$302,000.00 |
$156,000.00 |
$113,000.00 |
$139,000.00 |
$384,000.00 |
$600,000.00 |
$648,000.00 |
$170,000.00 |
$13,000.00 |
$435,000.00 |
| Depreciation &
Amortization |
$1.70 M
|
$887,000.00
|
$561,000.00
|
$620,000.00
|
$690,000.00
|
$1.50 M
|
$1.73 M
|
$1.86 M
|
$933,000.00
|
$745,000.00
|
| EBITDA |
-$13.20 M
|
-$14.04 M
|
-$9.09 M
|
-$15.07 M
|
-$11.06 M
|
-$24.89 M
|
-$26.74 M
|
-$21.60 M
|
-$18.64 M
|
-$32.59 M
|
| EBITDA Ratio |
-0.72 |
-1.21 |
-1.31 |
-1.3 |
-1.28 |
-2.43 |
-3.98 |
-2.27 |
-2.49 |
-3.16 |
| Operating Income Ratio
|
-0.83
|
-1.2
|
-1.23
|
-1.45
|
-1.2
|
-2.39
|
-4.3
|
-1.94
|
-2.49
|
-3.15
|
| Total Other
Income/Expenses Net |
-$86,000.00
|
$476,000.00
|
$4.06 M
|
-$2.97 M
|
$4.51 M
|
$38,000.00
|
$2.49 M
|
$4.12 M
|
$1.97 M
|
-$16.98 M
|
| Income Before Tax |
-$15.20 M |
-$15.08 M |
-$9.76 M |
-$15.83 M |
-$12.13 M |
-$26.99 M |
-$29.12 M |
-$23.47 M |
-$19.59 M |
-$33.77 M |
| Income Before Tax Ratio
|
-0.83
|
-1.17
|
-0.87
|
-1.78
|
-0.87
|
-2.38
|
-3.96
|
-1.65
|
-2.26
|
-6.34
|
| Income Tax Expense |
$0.00 |
-$476,000.00 |
-$1.33 M |
$1.13 M |
-$438,000.00 |
$1.27 M |
$944,000.00 |
-$6.17 M |
-$965,000.00 |
-$371,000.00 |
| Net Income |
-$15.20 M |
-$14.60 M |
-$8.43 M |
-$16.95 M |
-$11.69 M |
-$26.99 M |
-$29.12 M |
-$23.47 M |
-$19.59 M |
-$33.77 M |
| Net Income Ratio |
-0.83 |
-1.13 |
-0.75 |
-1.91 |
-0.84 |
-2.38 |
-3.96 |
-1.65 |
-2.26 |
-6.34 |
| EPS |
-1.1 |
-1.13 |
-0.69 |
-2.37 |
-2.44 |
-6.61 |
-12.27 |
-19.42 |
-15.53 |
-34.96 |
| EPS Diluted |
-1.1 |
-1.13 |
-0.69 |
-2.37 |
-2.44 |
-6.61 |
-12.27 |
-18.9 |
-15.52 |
-34.96 |
| Weighted Average Shares
Out |
$13.87 M
|
$12.96 M
|
$12.19 M
|
$7.16 M
|
$4.79 M
|
$4.08 M
|
$2.37 M
|
$1.21 M
|
$1.26 M
|
$965,875.00
|
| Weighted Average Shares
Out Diluted |
$13.87 M
|
$12.96 M
|
$12.27 M
|
$7.16 M
|
$4.79 M
|
$4.08 M
|
$2.37 M
|
$1.24 M
|
$1.26 M
|
$965,875.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
